Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Dec. 14 to 18, 2020. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Dec. 14 to 18, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
ACAAI: Reaction to COVID-19 Vaccine Unlikely for Those With Common Allergies
FRIDAY, Dec. 18, 2020 (HealthDay News) — Allergic reactions to vaccines are generally rare and people with common allergies are not more likely to have a reaction to the Pfizer-BioNTech COVID-19 vaccine, according to guidance released by the American College of Allergy, Asthma & Immunology.
U.S. Indigenous Communities Start Receiving COVID-19 Vaccines
FRIDAY, Dec. 18, 2020 (HealthDay News) — Indigenous communities in the United States have started receiving COVID-19 vaccines from federal and state agencies.
CDC: Concerning Increase Seen in Overdose Deaths During Pandemic
FRIDAY, Dec. 18, 2020 (HealthDay News) — In the 12-month period ending May 2020, the highest number of overdoses ever was recorded, topping 81,000, according to a health advisory issued by the U.S. Centers for Disease Control and Prevention.
Tocilizumab Cuts Progression to Ventilation or Death in COVID-19
FRIDAY, Dec. 18, 2020 (HealthDay News) — Tocilizumab reduces the risk for progression to ventilation or death among hospitalized patients with COVID-19 pneumonia, according to a study published online Dec. 18 in the New England Journal of Medicine.
Infants With COVID-19 May Present With GI Symptoms
FRIDAY, Dec. 18, 2020 (HealthDay News) — Among 10 infants hospitalized with COVID-19, most had mild disease and most commonly presented with gastrointestinal symptoms, according to a research letter published online Dec. 14 in JAMA Network Open.
Advisory Committee Votes to Recommend EUA for Moderna Vaccine
THURSDAY, Dec. 17, 2020 (HealthDay News) — The Moderna COVID-19 vaccine received recommendation from a U.S. Food and Drug Administration advisory committee on Thursday, clearing the way for it to become the second COVID-19 vaccine to be granted emergency use authorization.
71 Percent in U.S. Report That They Would Get COVID-19 Vaccine
THURSDAY, Dec. 17, 2020 (HealthDay News) — Seventy-one percent of the U.S. public report that they would definitely or probably get a COVID-19 vaccine, marking an increase from 63 percent in September, according to the ongoing research project, the KFF COVID-19 Vaccine Monitor.
Suicide Mortality Up for Blacks During Closure Period of COVID-19
THURSDAY, Dec. 17, 2020 (HealthDay News) — In Maryland, suicide mortality increased among Blacks and decreased among Whites during the progressive closure period of the COVID-19 pandemic, according to a research letter published online Dec. 16 in JAMA Psychiatry.
High-Income Countries Have Secured COVID-19 Vaccine Supplies
Significant Association ID"d Between Hepatitis C, Overactive Bladder .jpg)
Study Looks at Barriers to Initiation of Rotavirus Vaccine 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
